Search results
FDA approves first RSV vaccine for at-risk adults in their 50s
CBS News· 5 hours agoThe Food and Drug Administration has approved giving GSK's vaccine for respiratory syncytial virus...
FDA Approves Geron's First Commercial Drug, Competes With Bristol Myers Squibb's Blood Cancer Drug
Benzinga via Yahoo Finance· 15 hours agoOn Thursday, the FDA approved Geron Corporation's (NASDAQ:GERN) Rytelo (imetelstat) for adult...
FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding shot's reach
CNBC· 6 hours agoThe shot, called Arexvy, is the first vaccine cleared by the FDA to protect that population from...
FDA approves new method to ease back pain
WINK TV Southwest Florida· 9 hours agoThe FDA has approved a new way to ease back pain.
FDA approves Geron’s RYTELO for MDS associated anaemia
Pharmaceutical Technology via Yahoo Finance· 20 hours ago"FDA approves Geron’s RYTELO for MDS associated anaemia" was originally created and published by...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 11 hours agoThis is appealing to people who are uneasy with the newer mRNA technology. But the competitor...
US FDA staff raise no major concerns about Eli Lilly Alzheimer's drug
Reuters via Yahoo News· 2 days agoAn FDA analysis of trial data for Eli Lilly's experimental Alzheimer's drug donanemab released on...
FDA Reverses Juul Ban. What Comes Next?
InvestorPlace· 13 hours agoThe U.S.Food and Drug Administration (FDA) has changed its tone on Juul e-cigarettes and vapes as it reverses the ban it put in place on these products...
FDA Approves Moderna’s mRESVIA Vaccine | JD Supra
JD Supra· 22 hours agoOn May 31, 2024, Moderna announced that the FDA has approved its respiratory syncytial virus vaccine (“RSV”), mRESVIA (mRNA-1345). The vaccine...
FDA Approves Imetelstat for Rare Low-Risk Blood Cancer
Medscape· 24 hours agoThe approval for the first-in-class agent is "potentially practice changing" given the lack of treatment options for transfusion-dependent lower-risk MDS patients.